(1 - 10 from 12
)
Alexion and BioPath opens door to opportunities in the medical fieldthesouthernnews.org › › alexion-and-biopath-opens-door-to-o...
thesouthernnews.org
Apr 3, · Girish Nallur, CEO of Vistara Bioscience, was the featured speaker for March, who gave a presentation regarding proteomics, or the study of ...
Targeted Protein Degradation: From Drug Discovery to the Clinicwww.nyas.org › events › targeted-protein-degradation-from-drug-discover...
www.nyas.org
Girish Nallur, PhD. Vistara Bioscience. + Abstract. Vistara has built a new capability for targeting proteins via the ubiquitin proteasome system using ...
sorted by relevance / date